Pseudomonas aeruginosa : a Survey of Resistance in 136 Hospitals in Spain | Zendy

Emilio Bouza | Zendy; Fernando Garcı́a-Garrote | Zendy; Emilia Cercenado | Zendy; M. Marín | Zendy; MC Díaz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pseudomonas aeruginosa : a Survey of Resistance in 136 Hospitals in Spain

Author(s) -

Emilio Bouza,

Fernando Garcı́a-Garrote,

Emilia Cercenado,

M. Marín,

MC Díaz

Publication year - 1999

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.43.4.981

Subject(s) - ticarcillin , aztreonam , piperacillin , cefepime , tobramycin , ceftazidime , amikacin , meropenem , microbiology and biotechnology , imipenem , medicine , ciprofloxacin , tazobactam , pseudomonas aeruginosa , gentamicin , piperacillin/tazobactam , antibiotic resistance , biology , antibiotics , bacteria , genetics

We carried out a nationwide study with all of the isolates ofPseudomonas aeruginosa collected in a week in 136 hospitals in Spain. The data on 1,014 isolates included resistance to the following antimicrobials: piperacillin-tazobactam, 7%; meropenem, 8%; amikacin, 9%; tobramycin, 10%; piperacillin, 10%; ticarcillin, 13%; imipenem, 14%; ceftazidime, 15%; cefepime, 17%; ciprofloxacin, 23%; aztreonam, 23%; ofloxacin, 30%; gentamicin, 31%. The most frequent serotypes were O:1 (25.1%), O:4 (21.6%), and O:11 (11.3%).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research